NCT04879628 Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04877132 Compassionate Use Program for Olipudase Alfa Enzyme Replacement Therapy for Patients With Chronic Acid Sphingomyelinase Deficiency (ASMD) Status APPROVED_FOR_MARKETING Phase N/A
NCT04850599 Isatuximab, Carfilzomib, and Pomalidomide for the Treatment of Relapsed or Refractory Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04848779 A Prospective Study to Observe & Describe Clinical Outcomes of Alglucosidase Alfa Treatment in Patients ≤6 Months of Age With Infantile-onset Pompe Disease (IOPD) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04845958 A Non-Interventional National Study in Pediatric Patients With Unexplained Enlarged Spleen Status COMPLETED Phase N/A
NCT04823130 Dupilumab Effect on Pruritus Neuro-mechanisms in Patients With Atopic Dermatitis Status COMPLETED Phase PHASE4
NCT04781816 Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus Status COMPLETED Phase PHASE2
NCT04763616 Study of Isatuximab and Cemiplimab in Relapsed or Refractory Natural Killer/T-cell Lymphoid Malignancy Status COMPLETED Phase PHASE2
NCT04754945 Isatuximab as Upfront Therapy for the Treatment of High Risk AL Amyloidosis Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04751877 Multicenter Open Label Phase 3 Study of Isatuximab Plus Lenalidomide and Dexamethasone With/Without Bortezomib in the Treatment of Newly Diagnosed Non Frail Transplant Ineligible Multiple Myeloma Elderly Patients (≥ 65; < 80 Years). Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04751487 Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE3
NCT04724213 Development of an Assessment Tool for Health-related Quality of Life in Children and Adolescents With Pompe Disease Status COMPLETED Phase NA
NCT04724083 Inflammatory Pathways and Cardiac Growth Factors Associated With Fabry Disease Cardiomyopathy Status UNKNOWN Phase N/A
NCT04718870 Dupilumab-PEdiatric Skin Barrier Function and LIpidomics STudy in Patients With Atopic Dermatitis Status COMPLETED Phase PHASE4
NCT04717375 Study of SAR444881 Administered Alone and in Combination With Other Therapeutics in Participants With Advanced Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT04705051 Long-term Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) With Venglustat Status TERMINATED Phase PHASE3
NCT04704050 Effect of Dronedarone on Atrial Fibrosis Progression and Atrial Fibrillation Recurrence Status TERMINATED Phase PHASE4